← Back to patent-cliff list
CAS 357338-13-7
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide
Codes：BRIV-006
Application context (from source-drug indications)
癫痫部分性发作布瓦西坦癫痫布瓦西坦癫痫发作布瓦西坦
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 布瓦西坦Brivaracetam | Tier C — Watch / trade | 2028 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
pentanal→2-oxoacetic acid→morpholine hydrochloride→5-hydroxy-4-propylfuran-2(5H)-one→(S)-2-aminobutanamide→(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide→(S)-2-((S)-2-oxo-4-propylpyrrolidin-1-yl)butanamide→(S)-2-((R)-2-oxo-4-propylpyrrolidin-1-yl)butanamide
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications |
|---|---|---|---|---|---|
| Unibest Taizhou GMP-like Site | Brivaracetam Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
| Qualified Partner — East China API Works | (+)-(R)-4-propyl-4,5-dihydrofuran-2(3H)-one Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.